ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 591,44
-0,54%
Dow Jones
40 211,72
0,53%
DAX
18 504,42
-0,51%
Brent Oil
83,625
-0,85%
Bitcoin
62 811,48
-3,15%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Intellia Therapeutics Inc (NTLA)

  7. Intellia Therapeutics Inc (NTLA) Actualités

NTLA

Intellia Therapeutics (NTLA)

Intellia Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NTLA
DateHeureSourceTitreSymboleSociété
16/10/201914h00GlobeNewswire Inc.Intellia Therapeutics Announces Presentations at the 2019 Annual Congress of the European Society of Gene and Cell Therapy (E...NASDAQ:NTLAIntellia Therapeutics Inc
30/09/201914h00GlobeNewswire Inc.Intellia Therapeutics to Present at October Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
26/09/201923h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NTLAIntellia Therapeutics Inc
26/09/201922h30GlobeNewswire Inc.Arbitration Decision Affirms Intellia Therapeutics’ Interpretation of Licensing Agreement with Caribou Biosciences on the C...NASDAQ:NTLAIntellia Therapeutics Inc
13/09/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NTLAIntellia Therapeutics Inc
10/09/201917h19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NTLAIntellia Therapeutics Inc
30/08/201923h14Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:NTLAIntellia Therapeutics Inc
23/08/201923h20Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NTLAIntellia Therapeutics Inc
02/08/201922h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NTLAIntellia Therapeutics Inc
01/08/201923h17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NTLAIntellia Therapeutics Inc
01/08/201913h30GlobeNewswire Inc. Intellia Therapeutics Announces Second Quarter 2019 Financial Results and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
30/07/201914h00GlobeNewswire Inc.Intellia Therapeutics to Present at August Healthcare Investor ConferenceNASDAQ:NTLAIntellia Therapeutics Inc
25/07/201913h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
09/07/201914h54Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NTLAIntellia Therapeutics Inc
30/05/201922h30GlobeNewswire Inc.Intellia Therapeutics to Participate at June Healthcare Investor ConferencesNASDAQ:NTLAIntellia Therapeutics Inc
29/05/201922h25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NTLAIntellia Therapeutics Inc
28/05/201913h50GlobeNewswire Inc.Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific OfficerNASDAQ:NTLAIntellia Therapeutics Inc
09/05/201918h52Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201922h19Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:NTLAIntellia Therapeutics Inc
02/05/201913h30GlobeNewswire Inc.Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
29/04/201913h30GlobeNewswire Inc.Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Societ...NASDAQ:NTLAIntellia Therapeutics Inc
25/04/201913h30GlobeNewswire Inc.Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2019 Earnings and Company UpdateNASDAQ:NTLAIntellia Therapeutics Inc
16/04/201922h32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NTLAIntellia Therapeutics Inc
15/04/201922h30GlobeNewswire Inc.Intellia Therapeutics Announces Three Oral Presentations on In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeti...NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h41Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h39Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h26Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201914h00Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:NTLAIntellia Therapeutics Inc
27/02/201912h30GlobeNewswire Inc.Intellia Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial ResultsNASDAQ:NTLAIntellia Therapeutics Inc
14/02/201922h05Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:NTLAIntellia Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NTLA

Dernières Valeurs Consultées

EU
RNO
Renault
EU
VK
Vallourec
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
NASDAQ
AAPL
Apple
NASDAQ
MSFT
Microsoft
NASDAQ
NVDA
NVIDIA
NYSE
MRK
Merck
EU
EN
Bouygues
NYSE
NKE
Nike
COIN
BTCUSD
Bitcoin
EU
DG
Vinci
EU
LR
Legrand
EU
BEL20
Bel 20
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés